Nova Patents
IS7076A

One dose vaccination with i mycoplasma hyopneumoniae /i

Abstract

The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.

Term

Term ended

Projected expiry passed 15 December 2023, 2.8 years ago.

  1. Priority
  2. Filed and published
  3. Projected expiry
  4. Today

85 members in 42 offices

This recordMember, by publication datePriority claim32 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
30263601United States of AmericaP
30263601United States of AmericaP
0202121International Bureau of the World Intellectual Property Organization (WIPO)W
0202121International Bureau of the World Intellectual Property Organization (WIPO)W
PCTIB0202121–––
US20010302636P–––
WO2002IB02121–––

Members85

Family members, oldest first
DocumentOfficeKind
DOP2002000431ADominican RepublicA
CA2451626A1CanadaA1
WO03003941A2World Intellectual Property Organization (WIPO)A2
PA8549701A1PanamaA1
PE20030285A1PeruA1
UY27366A1UruguayA1
GT200200138AGuatemalaA
US2003109473A1United States of AmericaA1
IS7076AThis recordIcelandA
AP2003002937A0African Regional Intellectual Property Organization (ARIPO)A0
NO20035762LNorwayL
AR034678A1ArgentinaA1
KR20040030785ARepublic of KoreaA
IL159349A0IsraelA0
WO03003941A3World Intellectual Property Organization (WIPO)A3
EP1474067A2European Patent Office (EPO)A2
CN1551781AChinaA
MA27047A1MoroccoA1
US2005013823A1United States of AmericaA1
US6846477B2United States of AmericaB2
BG108546ABulgariaA
MXPA03011599AMexicoA
HK1068250AHong Kong, ChinaA
HK1068250A1Hong Kong, ChinaA1
BR0210804ABrazilA
JP2005515162AJapanA
CZ20033466A3CzechiaA3
EA200301323A1Eurasian Patent Organization (EAPO)A1
EP1474067A4European Patent Office (EPO)A4
PL373367A1PolandA1
SK15792003A3SlovakiaA3
HRP20031079A2CroatiaA2
TNSN03155A1TunisiaA1
YU102203AYugoslavia, later Serbia and Montenegro (until 2006)A
OA12638AAfrican Intellectual Property Organization (OAPI)A
UA78707C2UkraineC2
NZ530106ANew ZealandA
HU0400434A2HungaryA2
HUP0400434A2HungaryA2
AU2002309109B2AustraliaB2
EA009901B1Eurasian Patent Organization (EAPO)B1
EP1474067B1European Patent Office (EPO)B1
PT1474067EPortugalE
AT412426TAustriaT
ATE412426T2AustriaT2
DK1474067T3DenmarkT3
DE60229666D1GermanyD1
EP2027873A1European Patent Office (EPO)A1
ES2312580T3SpainT3
CN101524532AChinaA
HK1134900AHong Kong, ChinaA
HK1134900A1Hong Kong, ChinaA1
TWI329514BTaiwan Province of ChinaB
CA2451626CCanadaC
PL209773B1PolandB1
SK288010B6SlovakiaB6
CN1551781BChinaB
CN102872456AChinaA
USRE44399EUnited States of AmericaE
HK1180224AHong Kong, ChinaA
HK1180224A1Hong Kong, ChinaA1
CN101524532BChinaB
CY1108749T1CyprusT1
ZA200309698BSouth AfricaB
BG66481B1BulgariaB1
EP2842569A1European Patent Office (EPO)A1
EP2027873B1European Patent Office (EPO)B1
PT2027873EPortugalE
DK2027873T3DenmarkT3
ES2550458T3SpainT3
EP2027873B8European Patent Office (EPO)B8
HU230246B1HungaryB1
CN102872456BChinaB
HK1207584AHong Kong, ChinaA
HK1207584A1Hong Kong, ChinaA1
CZ305781B6CzechiaB6
CY1116862T1CyprusT1
EP1474067B2European Patent Office (EPO)B2
DK1474067T4DenmarkT4
ES2312580T5SpainT5
NO342654B1NorwayB1
EP2842569B1European Patent Office (EPO)B1
DK2842569T3DenmarkT3
PT2842569TPortugalT
ES2729579T3SpainT3